1. Atkinson RL, Berke LK, Drake CR, Bibbs ML, Williams FL, Kaiser DL (1985) Effects of long term therapy with naltrexone on body weight in obesity. Clin Pharmacol Ther 9: 347–353
2. Barrett RP, Feinstein C, Hole WT (1989) Effects of naloxone and naltrexone on self-injury: a double-blind placebo controlled analysis. American Journal of Mental Retardation 93: 644–651
3. Bouvard MP, Leboyer M, Launay JM, Kerdelhue B, Dugas M (1992) Opioid hypothesis in infantile autism. In: Naruse H, Ornitz EM (eds) Neurobiology of Infantile Autism. Excerpta Medica. Amsterdam, London, New-York, Tokyo
4. Bouvard MP, Leboyer M, Launay JM et al. (1995) Low dose naltrexone effects of on plasma chemistries and clinical symptoms in autism: a double-blind, placebo-controlled study. Psychiatry Research 58: 191–201
5. Campbell M, Anderson I, Small A, Locascio J (1990) Naltrexone in autistic children: a double blind and placebo-controlled study. Psychopharmacological bulletin 26: 130–135